tiprankstipranks
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market
ANTX
AN2 Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ANTX full AI Analyst Report?

AN2 Therapeutics, Inc. (ANTX) Cash flow

106 Followers

AN2 Therapeutics, Inc. Cash Flow

ANTX's free cash flow for Q4 2025 was $-5.24M. For the 2025 fiscal year, ANTX's free cash flow was decreased by $19.42M and operating cash flow was $-5.24M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Investing Cash Flow
$ 28.31M$ 54.59M$ -43.28M$ -21.77M$ -50.02M
Financing Cash Flow
$ 113.00K$ 372.00K$ 84.99M$ 70.36M$ 78.53M
End Cash Position
$ 19.94M$ 21.35M$ 15.65M$ 27.22M$ 12.10M
Free Cash Flow
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Currency in USD

AN2 Therapeutics, Inc. Cash Flow